These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 27638666)

  • 1. Cartilage damage and bone erosion are more prominent determinants of functional impairment in longstanding experimental arthritis than synovial inflammation.
    Hayer S; Bauer G; Willburger M; Sinn K; Alasti F; Plasenzotti R; Shvets T; Niederreiter B; Aschauer C; Steiner G; Podesser BK; Smolen JS; Redlich K
    Dis Model Mech; 2016 Nov; 9(11):1329-1338. PubMed ID: 27638666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal [
    Hayer S; Zeilinger M; Weiss V; Dumanic M; Seibt M; Niederreiter B; Shvets T; Pichler F; Wadsak W; Podesser BK; Helbich TH; Hacker M; Smolen JS; Redlich K; Mitterhauser M
    J Bone Miner Res; 2019 Sep; 34(9):1632-1645. PubMed ID: 31063606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK1 is not essential for TNF-mediated joint disease.
    Köller M; Hayer S; Redlich K; Ricci R; David JP; Steiner G; Smolen JS; Wagner EF; Schett G
    Arthritis Res Ther; 2005; 7(1):R166-73. PubMed ID: 15642137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis.
    Herrak P; Görtz B; Hayer S; Redlich K; Reiter E; Gasser J; Bergmeister H; Kollias G; Smolen JS; Schett G
    Arthritis Rheum; 2004 Jul; 50(7):2327-37. PubMed ID: 15248234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis.
    Korb-Pap A; Stratis A; Mühlenberg K; Niederreiter B; Hayer S; Echtermeyer F; Stange R; Zwerina J; Pap T; Pavenstädt H; Schett G; Smolen JS; Redlich K
    Ann Rheum Dis; 2012 Jun; 71(6):1004-11. PubMed ID: 22258493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural cartilage damage attracts circulating rheumatoid arthritis synovial fibroblasts into affected joints.
    Hillen J; Geyer C; Heitzmann M; Beckmann D; Krause A; Winkler I; Pavenstädt H; Bremer C; Pap T; Korb-Pap A
    Arthritis Res Ther; 2017 Feb; 19(1):40. PubMed ID: 28245866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis.
    Wäldele S; Koers-Wunrau C; Beckmann D; Korb-Pap A; Wehmeyer C; Pap T; Dankbar B
    Arthritis Res Ther; 2015 Jan; 17(1):12. PubMed ID: 25600705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
    Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
    J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
    Zwerina J; Hayer S; Redlich K; Bobacz K; Kollias G; Smolen JS; Schett G
    Arthritis Rheum; 2006 Feb; 54(2):463-72. PubMed ID: 16447221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially regulated expression of growth differentiation factor 5 and bone morphogenetic protein 7 in articular cartilage and synovium in murine chronic arthritis: potential importance for cartilage breakdown and synovial hypertrophy.
    Bobacz K; Sunk IG; Hayer S; Amoyo L; Tohidast-Akrad M; Kollias G; Smolen JS; Schett G
    Arthritis Rheum; 2008 Jan; 58(1):109-18. PubMed ID: 18163510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
    van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB
    Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt inhibitory factor 1 deficiency uncouples cartilage and bone destruction in tumor necrosis factor α-mediated experimental arthritis.
    Stock M; Böhm C; Scholtysek C; Englbrecht M; Fürnrohr BG; Klinger P; Gelse K; Gayetskyy S; Engelke K; Billmeier U; Wirtz S; van den Berg W; Schett G
    Arthritis Rheum; 2013 Sep; 65(9):2310-22. PubMed ID: 23784913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis.
    Cejka D; Hayer S; Niederreiter B; Sieghart W; Fuereder T; Zwerina J; Schett G
    Arthritis Rheum; 2010 Aug; 62(8):2294-302. PubMed ID: 20506288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
    Kaur S; White S; Bartold M
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The loss of α2β1 integrin suppresses joint inflammation and cartilage destruction in mouse models of rheumatoid arthritis.
    Peters MA; Wendholt D; Strietholt S; Frank S; Pundt N; Korb-Pap A; Joosten LA; van den Berg WB; Kollias G; Eckes B; Pap T
    Arthritis Rheum; 2012 May; 64(5):1359-68. PubMed ID: 22083543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.